Theravance Biopharma Inc

-0.09 (-1.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)509.21M
Current PEN/A
Forward PE N/A
2yr Forward PE 18.92
See more stats
Estimates Current Quarter
Revenue$14.69 Million
Adjusted EPS-$0.56
See more estimates
10-Day MA$7.37
50-Day MA$10.93
200-Day MA$16.64
See more pivots

Theravance Biopharma Inc Stock, NASDAQ:TBPH

Ugland House, South Church Street, George Town, George Town KY1-1104
Cayman Islands
Phone: +1.650.808.6000
Number of Employees: 359


Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.